In a May 7, 2024 press release, Seragon Biosciences announced that its aging intervention drug candidate, SRN-901, achieved one of the largest extensions of
RESTORIN activates key longevity pathways like DNA repair, mTOR inhibition, and cognitive support, offering a scientifically-backed approach to extending healthspan.
Scientists are unlocking the secrets of aging, aiming to extend healthy human lifespan through groundbreaking research in senolytics, metformin, and gene editing technologies.